朝雲集團(06601.HK)獲主席兼執行董事陳丹霞增持共100萬股
格隆匯4月26日丨朝雲集團(06601.HK)發佈公吿,公司董事會已獲吿知,於2022年4月25日至2022年4月26日期間,公司主席兼執行董事陳丹霞女士以總代價約236萬港元於公開市場進一步購入公司合共100萬股股份,相當於本公吿日期本公司已發行股份總數約0.075%。
緊隨增持事項後,陳女士持有公司合共349.35萬股股份,相當於本公吿日期公司已發行股份總數約0.262%。
陳女士對公司的未來前景充滿信心,相信公司整體業務持續穩定健康發展,同時戰略孵化業務高速發展,並可能考慮日後於適當時候進一步增持並於公司的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.